Inflammatory markers such as CRP, TNF-α, and IL-6 are associated with higher tumor grade and risk of mortality in CRC patients and are elevated in the blood of CRC patients compared to healthy controls [203]. The gene discussed is IL6; the disease is colorectal carcinoma.